In early January 2024, a widely publicized article in the journal Biomedicine and Pharmacology estimated that approximately 17,000 COVID-19 patients in France, Italy, Spain, Turkey, and the US died as a result of hydroxychloroquine treatment.
Osorio-de-Castro, Claudia Garcia Serpa +3 more
core
PREVALENCE AND RISK FACTORS ASSOCIATED WITH NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH RHEUMATOID ARTHRITIS ON HYDROXYCHLOROQUINE: A POPULATION-BASED STUDY. [PDF]
Boustany A +11 more
europepmc +1 more source
Pregnancy and kidney transplantation: optimized clinical and obstetric management to reduce maternal and perinatal complications. [PDF]
Santos ACM +4 more
europepmc +1 more source
[Impact of an integrated and centralized drug policy: the case of the province of Buenos Aires, ArgentinaImpacto de uma política de medicamentos integrada e centralizada: o caso da província de Buenos Aires, Argentina]. [PDF]
Marín GH +7 more
europepmc +1 more source
Evidence syntheses to support decision-making related to the Covid-19 pandemic. [PDF]
Andrade KRC +14 more
europepmc +1 more source
[Ischaemic stroke associated with COVID-19 in dialysis patients]. [PDF]
de Lorenzo A +6 more
europepmc +1 more source
[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review]. [PDF]
Trujillo Gittermann LM +2 more
europepmc +1 more source
Whipple's Disease as a Differential Diagnosis of Blood Culture-Negative Endocarditis: A Case Report. [PDF]
Soares CK +5 more
europepmc +1 more source
[Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19]. [PDF]
Monte Serrano J +3 more
europepmc +1 more source
QT interval prolongation in geriatric patients treated for SARS-COV-2 infection: OCTA-COVID study. [PDF]
Garmendia-Prieto B +2 more
europepmc +1 more source

